Ascendis Pharma
ASND
$135.10
Share price
-1.71%
Change (1 day)
53.59%
Change (1 year)
Categories
Ascendis Pharma (ASND) - P/B ratio
P/B ratio as of June 2024 : -30.5
According to Ascendis Pharma
's latest financial reports the company has a price-to-book ratio of -30.5.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ascendis Pharma - P/B ratio (from 2015 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | -44.2 | -279.05% |
| 2022-12-31 | 24.7 | 222.96% |
| 2021-12-31 | 7.65 | -11.46% |
| 2020-12-31 | 8.64 | -13.47% |
| 2019-12-31 | 9.98 | 21.12% |
| 2018-12-31 | 8.24 | 27.11% |
| 2017-12-31 | 6.48 | 83.78% |
| 2016-12-31 | 3.53 | 0.81% |
| 2015-12-31 | 3.50 | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | -8.30 | -72.81% | 🇺🇸 USA |
 Affimed
AFMD | 0.9673 | -103.17% | 🇩🇪 Germany |
 Advaxis ADXS | -0.4623 | -98.49% | 🇺🇸 USA |